🇺🇸 FDA
Pipeline program

SYHA1813 oral solution (2.0g:25mg)

SYHA1814-003

Phase 1 small_molecule completed

Quick answer

SYHA1813 oral solution (2.0g:25mg) for Healthy Participants is a Phase 1 program (small_molecule) at Shanghai University of Traditional Chinese Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai University of Traditional Chinese Medicine
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials